Both plastic surgery societies, which will be represented at the upcoming hearings of the U.S. Food and Drug Administration (FDA) Advisory Panel in Gaithersburg, MD, April 11-13, 2005, urge the FDA to conduct a fair hearing based on sound science, not emotion.
ASAPS and ASPS have confidence that the FDA will make its decision based on the best interests of patients, not on junk science or personal anecdotes. Plastic surgeons are committed to helping women make informed choices about their health care based on all available and accurate information about these devices.
"All surgical procedures are about informed patient choice," said Mark Jewell, MD, ASAPS President-Elect. "Our primary concerns are patient safety and satisfaction. What is ultimately important to every plastic surgeon is that medical devices used for breast surgery are safe."
"Breast implants, as with any other medical device, do not last a lifetime," said James Wells, MD, ASPS past president. "No medical device is flawless and neither are silicone implants or saline, for that matter. The FDA's initial findings which are critical of the implants tell only part of the story in its recently posted comments. These observations are contained in nearly 200 pages and certainly need to examined, however, they need to be considered in context of the entire breadth of epidemiologic research and scientific study. If the science supports the safety and effectiveness of these devices, women deserve to have silicone implants as a choice.